Summary: A rapid and specific assay for human serum caleitonin is described.
Introduction
Since the introduction of a radioimmunoassay (RIA) for human caleitonin (1, 2) the following problems have not been fully resolved:
(1) Long assay time -usually in the order of several days (1,2). (2) Sensitivity -thus requiring an extraction step for measurement in normal persons (3) . (3) Separation -the use of non-specific separation of bound and free hormone (4) .
This study has taken these points and developed an assay which gives results inside 30 h, needs no extraction and uses a second antibody-polymer separation step (5) . To prove the reliability of the assay, parallel-dilution tests, as well as a clinical study have been conducted over a 12 month-period, including sera from patients with medullary thyroid carcinoma, bronchial carcinoma and calcium metabolism disturbances.
I-human calcitonin was produced by a modified Hunter & Greenwood method as published elsewhere for parathyrin (7) and had a shelf-life of longer than 3 months. Purification of label was effected by means of a 9 X 1 cm Sephadex G-10 column and the labelled human calcitonin stored in buffer 2 (see table 1 ). The assay was carried out as in table 1. 
Results

Preliminary Studies
Antibody Dilution Curve An antibody concentration of 1:10 000 (initial dilution) was chosen to give a B 0 /T ratio of around 0.2 after an incubation time of 6 h at 4 °C.
Affinity Studies
A Scatchard-plot carried out unter the assay conditions gave a population of antibodies with an affinity constant of 0.31 Χ 10 11 liter -mof 1 and shows why the assay can be carried out in such a short time. A second population of low affinity-high capacity antibodies with an affinity constant of 0.28 Χ 10 9 liter · mol" 1 was also seen. Figure 1 shows the kinetics of the zero and 2.5 μ% -liter" 1 standards over a 7 h period after a 15 h preincubation at 4 °C. The second incubation was set at 4.5 h from these results. The pre-incubation was set at 15 h -i.e. overnight -as a part of the rationalisation programme. A preincubation step was included to increase sensitivity as shown for other peptide hormones (8).
Kinetic Studies of Tracer Binding
Tab. 1. Assay details showing incubation, separation and counting steps.
Pre-incubation 18 h 4 ° C 100 μΐ "Standard or serum 100 μΐ anti human calcitonin (1:10,000 initial dilution) in ""buffer 2 Figure 2 shows the purification of the label over Ultrogel AcA 54 after desalting of the reaction-mixture on Sepha- dex G-10. It can be seen that no further purification than Sephadex G-10 is required as over 95 % immunoreactivity is distributed over a single peak. The small forepeak (peak IV) has little or no effect on the assay system. Table 3 shows several serum components before and after extraction (100 g Florisil per liter serum). Figure 3 shows the radioactivity bound before and after Florisil in 7 sera and table 3 the electrophoretic pattern and concentration of several serum components before and after treatment.
Main Incubation
Tracer -Preparation and Purification
Preparation of "human calcitonin free serum"
Figures 4a-4d show the effect of varying one component of the extraction system. The basic extraction system consisted of Florisil 200 g · liter" 1 and an extraction time of 30 min at room temperature under constant shaking. The variable parameter is shown in the x-axis of figures 4 a4d. The tracer purity (tracer 10 weeks old) was estimated to be between 50 % and 60 % using column chromatography (estimated purity 52%) and excess antibody binding (estimated purity 58 % showed that Florisil extracted immunoreactive human calcitonin to within the expected limits. The system chosen for the extraction of the sera shown in figure 3 was that given above.
Assay Conditions
Assay Standard Curves Figure 5 shows a typical standard curve for the human calcitonin assay. The effect of changing the amount of serum in one experiment had the following effect on the 50 % intercept: With 50 μΐ serum the 50 % intercept was 2.86 μg ' liter" 1 , with 100 μΐ serum, 1.55 Mg · liter" 1 , and with 200 μΐ serum, 1.09 Mg ' liter" 1 . The 50 μΐ assay showed a pronounced "hook-effect" which was not present with larger serum amounts.
In the earlier studies, 15 % polyethyleneglycol was used as precipitant as also described elsewhere for parathyrin (9) . Owing to unspecific effects with sera from patients with disproteinaemia -mainly dialysis patients, or those with Waldenstrom's disease -this method was changed to a double-antibody procedure, especially when the latter could be performed rapidly (5) . Figure 6 shows the effect of diluting two sera from patients with medullary-thyroid carcinoma, serum A from a dialysis patient and serum Β from a patient with normal Table 2 shows the intra-and interassay CV over the whole range of the standard curve. The interassay CV was carried out over a 3 month-period. Figure 7 a shows the immunoreactive human calcitoninlevels found in 52 normal patients compared with a group of 8 patients with medullary thyroid carcinoma, 29 patients with bronchial tumors, 5 phaeochromocytoma patients, and 57 patients with calcium metabolism disorders (renal stones, hyper-and hypoparathyruiaemia). Only the patients with medullary thyroid carcinoma and confirmed multiple endocrine adenoma H-cases showed significantly elevated human calcitonin levels.
Parallelism Studies
Intra* and Interassay Coefficients of Variation (CV)
Clinical Studies
The normal collective had a normal calcium metabolism, were aged 18-67 years and were distributed evenly between the sexes (cJ, 9 = 26). The difference in human calcitonin levels between the sexes in the normal collective was not statistically significant (p 0.2 (Wilcoxpn Rank test)). Six patients with phaeochromocytoma were studied and their human calcitonin levels ranged from 0.04-1.28 Mg · liter" 1 . Figure 7b shows patients with disturbed calcium metabolism, measured at the same time, including the patients with medullary thyroid carcinoma and 14 normal volunteers. Two dialysis patients showed slightly elevated values. Figure 8 shows the pre-and postoperative human calcitonin levels in a patient with lung metastases from a medullary thyroid carcinoma during cytostatic treatment. Clinical symptoms correlated well, but cytostatic treatment had to be discontinued due to severe side-effects in the haematopoietic system.
Discussion
Although the assay for human calcitonin in serum is very rarely an emergency one, the need for rapid and sensitive assays is present, especially in rationalisation of assay procedures; and also because of the theoretical consideration that the quicker the assay, the less the likelihood that degradation of the hormone may give rise to false results. The affinity constant of the antiserum used here 
Hypoĉ alcaemia (5) Hypercalcaemia makes it possible to run such quick assays without loss of sensitivity. The addition of aprotinin to the buffer system was to prevent protease activity -or at least hinder it. Non equilibrium assay conditions have been shown to be more sensitive than equilibrium ones (10) , and this, coupled with pre-incubation, improves the sensitivity/assay time relationship.
The use of non-specific precipitation methods was tried out at first using polyethyleneglycol, but due to the tinspecific effects in disproteinaemic sera (11) , this was only used until a double-antibody technique was perfected. The disadvantage of adding double-antibody alone was the slow kinetics (5) but with addition of polyethyleneglycol to a final concentration of 30-50 gliter"
1 this reaction was speeded up by over 1000-fold (5), so that the method was as quick as polyethyleneglycol and quicker than charcoal (2) without the time dependency of the latter. The quality-control of the assay is satisfactory as seen in table 2. The capacity of the assay to measure human calcitonin accurately is seen in the assay of sequentially diluted sera where the expected value lay very near to the measured value. The acquisition of human calcitonin-free serum by extraction with Florisil, although not all sera are useable.
It has been observed that when sera are not frozen at under -20 °C within 24 h of receipt that a loss of immunoreactivity is seen, i.e. the binding in the assay falls off, giving rise to falsely elevated results. Treatment with Florisil does not restore the immunoreactivity. Samples F and BR in figure 3 show this effect, and it must be put forward that this is not due to a change in human calcitonin (which would have to be generated!) but to degradation of component(s), perhaps in the complement system, which enhance the antigen-antibody reaction.
The use of the human ealcitonin assay in clinical diagnosis has been intensively investigated and also reports have been given where serum human calcitonin levels are raised in patients with various tumors (3, 12) other than medullary thyroid carcinoma. In this laboratory, consistenly elevated-levels have only been found in patients with medullary thyroid carcinoma.
In two patients, mother and daughter, with phaeochromocytoma removed 6 months and 12 years before, but without confirmed medullary thyroid carcinoma elevated human calcitonin was found which agree with the symptoms of multiple endocrine neoplasia type II (13) . The value of human calcitonin as a general tumor marker is doubtful in the light of the present study. In the patients with bronchial carcinoma, serum corticotropin levels were also normal (Müller, O. A., unpublished results) in contrast to other studies (14, 15) . One reason for this discrepancy may very well be due to the specificity of the antisera used, i.e. whether it is C-or N-regional specific (15) , and future studies must be carried out to determine the specificity of the antiserum to different regions of human calcitonin.
The use of the human calcitonin-assay using this antisera seems to be limited to the detection and followup of medullary thyroid carcinoma, and multiple endocrine adenoma type II in which production of human calcitonin can occur both in the adrenal medulla and the C-cells of the thyroid as both have a common embryological source.
